Pharmafile Logo
Pharmafocus logo
Advanced Search

Théa Open Innovation and Galimedix announce partnership for development and commercialisation of GAL-101

April 3, 2023
Sales and Marketing

Théa Open Innovation (TOI) and Galimedix have announced that they have signed a licensing agreement granting TOI exclusive rights for …

News
ed-us-k0dml4nmopo-unsplash

aVaxziPen announces positive data for multiple diseases with novel needle-free vaccine

April 3, 2023
Research and Development

aVaxziPen, a biotech company focusing on the development of a novel needle-free vaccine delivery platform, has announced that it will …

News
david-travis-avvzjc0ynbq-unsplash_1

Pixium Vision’s Prima System granted FDA Breakthrough Device Designation

April 3, 2023
Medical Communications

French bioelectronics company Pixium Vision has been granted Breakthrough Device Designation by the FDA for its Prima System.   Prima …

News
pawel-czerwinski-kxblpqfyc9e-unsplash

AstraZeneca’s NMOSD treatment recommended marketing authorisation by CHMP

April 3, 2023
Medical Communications

Pharma giant AstraZeneca has been given a recommendation by the EU’s Committee for Medicinal Products (CHMP) for marketing authorisation for …

News

CrestOptics launches CICERO system to provide all-in-one solution for widefield and spinning disk confocal microscopy

April 3, 2023
Business Services

Rome, IT, 03 April, 2023: CrestOptics S.p.A., a manufacturer of high-end microscopy solutions and advanced systems for fluorescence microscopy and …

News
Press release

Sequana Medical announces submission of Investigational New Drug (IND) application for DSR® 2.0 for treatment of congestive heart failure

April 3, 2023
Business Services

Ghent, Belgium – 03 April 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana

News
Press release

Novo Nordisk Foundation to support crucial education of health professionals in India and East Africa with up to DKK 1bn (USD 140m)

April 3, 2023
Business Services

Lack of access to qualified health personnel combined with an alarming prevalence of noncommunicable diseases (NCDs) such as cardiometabolic diseases …

News
Press release

Redx Confirms Proposed Business Combination with Jounce has Formally Lapsed

April 3, 2023
Business Services

Alderley Park, UK, 3 April 2023 Redx (AIM:REDX), the clinical-stage biotechnology company focused on discovering and developing novel, small molecule, …

News
Press release

Almirall: The New England Journal of Medicine (NEJM) and the British Journal of Dermatology (BJD) publish Ph3 data evaluating lebrikizumab efficacy and safety in moderate-to-severe atopic dermatitis

March 31, 2023
Business Services Almirall, Dermatology, dermatology, lebrikizumab

BARCELONA, Spain. March 31, 2023 – Almirall, S.A. (ALM), a global biopharmaceutical company focused on medical dermatology, announced today the …

News
Press release

HUTCHMED Completes Rolling Submission of NDA to U.S. FDA for Fruquintinib for the Treatment of Refractory Metastatic Colorectal Cancer

March 31, 2023
Business Services

Hong Kong, Shanghai & Florham Park, NJ — Friday, March 31, 2023: HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM, HKEX:​13) today announces that …

News
Press release

Abbott gains FDA approval for Epic Max tissue valve for the treatment of aortic valve disease

March 31, 2023
Medical Communications

Abbott has announced that the FDA has approved its Epic Max stented tissue valve to treat patients with aortic regurgitation …

News

First over-the-counter opioid overdose treatment approved by FDA

March 31, 2023
Medical Communications

The FDA has announced that it has approve Narcan, 4mg naloxone hydrochloride nasal spray for over-the-counter (OTC), non-prescription use. This …

News

NEC streamlines AI drug development with subsidiary reshuffle

March 31, 2023
Medical Communications

Japan-based NEC Corporation has announced that it is realigning its subsidiaries in order to streamline its AI drug development services. …

News

Nanoscope Therapeutics announces positive results from phase 2b trial in Retinitis Pigmentosa

March 31, 2023
Medical Communications

US-based Nanoscope Therapeutics has announced topline results from its phase 2b RESTORE clinical trial. Currently, patients with vision loss due …

News

Expansion of Scientific Affairs Group

March 30, 2023
Business Services

Ellipses Pharma (“Ellipses”), a global drug development company focused on accelerating the development of cancer medicines and treatments through an …

News
Press release

Roz Bekker appointed Managing Director of Janssen UK & Ireland

March 30, 2023
Business Services

High Wycombe, UK, 30 March 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson are pleased to introduce Roz …

Appointment

Granular Therapeutics to accelerate development of next-generation pipeline for treating mast cell driven diseases

March 30, 2023
Business Services

London, UK, March 30, 2023 – Granular Therapeutics, (Granular) a private biotech company specialising in precision biologic therapies for treating …

News
Press release

Trobix Bio Raises $3 Million from Chartered Group to Advance Precision Microbiome Oncology Therapeutics

March 30, 2023
Business Services

Netanya, Israel, March 30, 2023 – Trobix Bio, a company utilizing CRISPR, phage, and synthetic biology technologies to develop advanced …

News
Press release

PHARMANOVIA EXPANDS EXCLUSIVE LICENSING COLLABORATION WITH AQUESTIVE THERAPEUTICS FOR DIAZEPAM BUCCAL FILM

March 30, 2023
Business Services

Basildon, UK – For immediate release, 27 March 2023   Pharmanovia, a global pharmaceutical company that revitalises, extends and expands …

News
Press release

Unite Health: Thousands Honor Pandemic ‘Influencers’ Through COVID-19 Social Media Awards

March 30, 2023
Business Services

  London, UK | In a global display of appreciation, thousands of people are recognizing social media influencers who used …

News
Press release
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026